Incidence of Autoimmune Thyroid Disorders Following Treatment With Pegylated Interferon Therapy for HCV Infection Among Egyptian Patients

Endocrine Abstracts
doi 10.1530/endoabs.37.ep1000
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients

PLoS ONE
Multidisciplinary
2015English

Dermatological Manifestations of Pegylated Interferon Alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients

Afro-Egyptian Journal of Infectious and Endemic Diseases
2016English

Interferon-Λ in HCV Infection and Therapy

Viruses
VirologyInfectious Diseases
2010English

Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction

Acta Hepatologica Japonica
Hepatology
2013English

Autoimmune Thyroid Disorders

Journal of Thyroid Research
EndocrinologyMetabolismDiabetes
2011English

Cost-Effectiveness of Hepatitis C Virus (HCV) Treatment With Telaprevir/Pegylated Interferon Alpha/Ribavirin Triple Therapy Versus Waiting for New Regimens in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Severe Psoriasis Emerged After Treatment of Chronic HCV Co-Infection With Pegylated-Interferon and Ribavirin, Supported by Neutropenia Rescue With Repeated Filgrastim Administration

Retrovirology
VirologyInfectious Diseases
2010English

Changes in T-Cell Subsets in HIV–HCV-coinfected Patients During Pegylated Interferon-Α2a Plus Ribavirin Treatment

Antiviral Therapy
Infectious DiseasesPharmacology
2010English

The Effect of Pegylated Interferon-Alpha2b and Ribavirin Combination Therapy for Chronic Hepatitis C Infection in Elderly Patients

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy